Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency [NA]

View source ↗

Summary

Completed clinical trial evaluating Sculptra for correcting midface volume deficit and midface contour deficiency; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sculptra (poly-L-lactic acid)

Snippet

Sponsor: Galderma R&D | Conditions: Midface Volume Deficit | NA | Status: COMPLETED | Results posted: 2024-12-19